Drug Database
Back to search

Netherlands· NL-20dd409eb5f9

Rhophylac 200 microgram/2 ml, oplossing voor injectie in een voorgevulde spuit

A anti-d (rh) immunoglobulin product containing immunoglobuline, humaan, rhesus (anti-d), registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC J06BB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRhophylac 200 microgram/2 ml, oplossi…ATCJ06BB01REGISTER NO.NL-20dd409eb5f9PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about immunoglobuline, humaan, rhesus (anti-d)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Anti-d (rh) immunoglobulin is registered in 11 of 19 countries.

Countries holding a registration under ATC J06BB01 (anti-d (rh) immunoglobulin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search anti-d (rh) immunoglobulin products by name

Anti-d (rh) immunoglobulin · ATC J06BB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
IMMUNOGLOBULINE, HUMAAN, RHESUS (ANTI-D)
Manufacturer
Medcor Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
J06BB01
ATC class
Anti-D (rh) immunoglobulin
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    136722//27449

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Anti-d (rh) immunoglobulin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All anti-d (rh) immunoglobulin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Rhesonativ, Rhophylac
  • Belgium · Immunorho, Rhophylac
  • Bulgaria · Резонатив
  • Cyprus · Rhesonativ, Rhophylac
  • Czechia · Igamad, Rhesonativ
  • Germany · Rhesonativ, Rhophylac
  • Denmark · Rhesonativ, Rhophylac
  • Estonia · Rhesonativ
  • Spain · Igamad, Rhophylac
  • Finland · Rhophylac
  • France · Rhesonativ, Rhophylac
  • United Kingdom (Northern Ireland) · D-Gam, Rhophylac
  • Greece · Rhophylac
  • Hungary · Rhesonativ, Rhophylac
  • Ireland · Rhophylac
  • Iceland · Rhesonativ, Rhophylac
  • Italy · Igamad, Immunorho
  • Lithuania · Rhesonativ
  • Luxembourg · Rhesonativ, Rhophylac
  • Latvia · Rhesonativ
  • Malta · Rhesonativ, Rhophylac
  • Norway · Rhesonativ, Rhophylac
  • Poland · Gamma Anty-D, Rhesonativ
  • Portugal · Rhesonativ, Rhophylac
  • Romania · Rhesonativ, Rhophylac
  • Sweden · Rhesonativ, Rhophylac
  • Slovenia · Rhesonativ, Rhophylac
  • Slovakia · Igamad, Rhesonativ

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fa4986d8-ca54-458f-a44e-641283817e92
GET /v1/drugs/fa4986d8-ca54-458f-a44e-641283817e92?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intramusculair gebruik, Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h27449_smpc.pdf",
  "strength": null,
  "atc_label": "Anti-D (Rh) Immunoglobulin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg136722",
  "excipients": [
    "AZIJNZUUR (E 260)",
    "CHLORIDE (CL-)",
    "GLYCINE (E 640)",
    "HUMAAN ALBUMINE",
    "NATRIUM (NA+)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "IMMUNOGLOBULINE, HUMAAN, RHESUS (ANTI-D)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h136722.pdf",
  "authorised_at": "2026/06/30",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "136722//27449",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about anti-d (rh) immunoglobulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console